Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2026 Earnings Call Transcript April 27, 2026
Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.31.
Operator: Good morning, and welcome to Fulcrum Therapeutics First Quarter 2026 Financial Results and Business Update Conference Call. [Operator Instructions] This call is being webcast live and can be accessed on the Investors section of Fulcrum’s website at www.fulcrumtx.com and is being recorded....
